Filter By Category
Archives
Share on -
ALISVETCEL
Generic Name: ALISVETCEL
ABSTRACT -
Alisvetcel is an international nonproprietary name for an equine allogeneic chondrogenic-induced mesenchymal stromal cell product derived from donor-horse peripheral blood mononuclear cells. It is a cell-therapy product intended for veterinary specialist use, not a conventional small-molecule drug. Because cell products vary by manufacturing process and indication, dosing and administration must follow the specific veterinary protocol or approved product information.
DOSAGE -
- Alisvetcel does not have a universal human dosage regimen and is not intended for routine human use.
- Any veterinary use must follow the authorized product information, manufacturing controls, route, dose, and repeat-treatment schedule specified by the veterinarian or protocol.
- Cell products are typically administered only by trained professionals using aseptic technique and appropriate handling conditions.
- Do not substitute, dilute, freeze, thaw, or re-administer unless permitted by the product-specific instructions.
SIDE EFFECTS–
- Reported or potential side effects may include:
- Local pain, swelling, warmth, or inflammation at the administration site
- Temporary lameness or discomfort in treated animals
- Fever or malaise
- Inflammatory flare
- Infection or contamination risk if handling is improper
- Immune reaction to allogeneic cells
- Reduced response or treatment failure
- Allergic or hypersensitivity reactions
ALLRGIC REACTIONS–
(These symptoms may indicate an allergic reaction to the drug.)
- Skin rash
- Itching
- Hives
- Swelling of face, lips, tongue, or throat
- Difficulty breathing
- Wheezing
- Severe dizziness
- Rapid heartbeat
- Chest tightness
- Anaphylaxis
- Severe hypersensitivity reactions
DRUG INTERACTIONS–
- The interaction profile may include or require caution with:
- Corticosteroids or immunosuppressants that may alter cell activity
- Non-steroidal anti-inflammatory drugs when restricted by the veterinary protocol
- Other intra-articular, intralesional, or regenerative treatments
- Antibiotics, antiseptics, or local anesthetics used during procedures
- Vaccination or active infection considerations
- Other investigational veterinary biologics
- Patients should inform healthcare providers about all prescription medicines, non-prescription medicines, herbal products, and supplements being used.
PREAUTIONS–
- Use only under veterinary specialist supervision with product-specific storage and handling controls.
- Confirm species, diagnosis, lesion location, infection status, and eligibility before administration.
- Use aseptic technique and follow cold-chain, thawing, and timing instructions exactly.
- Monitor treated animals for pain, swelling, fever, lameness, infection, and response to therapy.
- Do not use in humans and keep biological material away from unauthorized handlers.
WARNINGS –
- Cell therapies can cause inflammatory, immune, or infectious complications if used improperly.
- Severe swelling, fever, marked lameness, discharge, or suspected joint infection requires urgent veterinary evaluation.
- Use only the intended product for the intended species and indication.
- Do not use expired, damaged, contaminated, or improperly stored cell preparations.
- Dispose of biological materials according to veterinary and biosafety requirements.
Share on -
. Developed by